echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Secondary analysis of the RACECA study: Can patients with acute large vessel occlusion with RACE ≥ 5 be directly transferred to an endovascular treatment center for treatment? 丨ISC2021

    Secondary analysis of the RACECA study: Can patients with acute large vessel occlusion with RACE ≥ 5 be directly transferred to an endovascular treatment center for treatment? 丨ISC2021

    • Last Update: 2021-03-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The RACECAT trial is a multi-center, prospective, randomized controlled trial designed to determine suspected acute large vessel occlusion (LVO) with a rapid assessment of arterial occlusion scale (RACE) ≥5 for emergency medical services (EMS) evaluation.
    For patients, whether directly transferred to the endovascular treatment center (EVT-SC group) has a higher proportion of good outcomes than transfer to the local stroke center (SC group).

    The results of the study will be announced at the International Stroke Conference 2021 (ISC2021).

    Author: Medical team doctors report NMT NMT ISC finishing compiler, please do not reprint without authorization.

     Study Introduction The trial was completed in June 2020 and included a total of 1401 patient samples.

    The main research methods are shown in the figure below.

     Main findings: The main analysis found that there was no clinical difference in the 90-day outcome between patients selected by EMS and patients who were finally diagnosed with ischemic stroke (adjusted OR: 0.
    990; 95% CI: 0.
    789-1.
    243).

    Among them, 67% of patients with ischemic stroke were diagnosed with LVO, and the proportion of patients who eventually received EVT was 41% in the SC group and 50% in the EVT-SC group.

    Conclusion The results of this study suggest that whether patients can benefit from a certain type of transport may depend on the distance from the location of the disease to the EVT center.

     Yimaitong compiled from: Secondary Analysis of the Racecat Trial: Benefit of Direct Transfer to an Endovascular Stroke Center According to the Presence of Large Vessel Occlusion and the Transfer Time to the Endovascular Center.
    ISC2021.
    -neurology), check the latest information of ISC 2021 at the same time! Long press the QR code to follow the ISC 2021 special report ☟☟☟ You can also click "read the original text" to see more ISC 2021 special related content!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.